DaVita Inc. (NYSE:DVA) Shares Sold by Utah Retirement Systems

Utah Retirement Systems decreased its holdings in DaVita Inc. (NYSE:DVAGet Rating) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,187 shares of the company’s stock after selling 200 shares during the quarter. Utah Retirement Systems’ holdings in DaVita were worth $844,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of DVA. Ellevest Inc. increased its holdings in shares of DaVita by 1,388.0% in the 3rd quarter. Ellevest Inc. now owns 372 shares of the company’s stock valued at $31,000 after purchasing an additional 347 shares in the last quarter. Eisler Capital UK Ltd. purchased a new position in DaVita in the third quarter valued at about $35,000. Parkside Financial Bank & Trust lifted its position in shares of DaVita by 88.6% during the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock valued at $35,000 after acquiring an additional 147 shares during the period. Wipfli Financial Advisors LLC acquired a new stake in shares of DaVita in the 3rd quarter worth approximately $44,000. Finally, AIA Group Ltd purchased a new position in DaVita in the 2nd quarter valued at approximately $51,000. Institutional investors and hedge funds own 86.52% of the company’s stock.

DaVita Trading Up 0.5 %

Shares of DVA opened at $75.06 on Tuesday. DaVita Inc. has a fifty-two week low of $65.28 and a fifty-two week high of $124.81. The stock has a fifty day moving average of $80.90 and a two-hundred day moving average of $80.86. The company has a debt-to-equity ratio of 9.92, a quick ratio of 1.16 and a current ratio of 1.20. The company has a market capitalization of $6.79 billion, a PE ratio of 12.99, a price-to-earnings-growth ratio of 1.49 and a beta of 0.95.

DaVita (NYSE:DVAGet Rating) last released its earnings results on Wednesday, February 22nd. The company reported $1.11 EPS for the quarter, beating the consensus estimate of $0.88 by $0.23. The firm had revenue of $2.92 billion during the quarter, compared to analyst estimates of $2.93 billion. DaVita had a return on equity of 74.02% and a net margin of 4.83%. The business’s quarterly revenue was down .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 earnings per share. As a group, analysts forecast that DaVita Inc. will post 5.93 EPS for the current year.

Analyst Ratings Changes

A number of analysts have commented on DVA shares. Truist Financial boosted their target price on DaVita from $84.00 to $90.00 and gave the stock a “hold” rating in a research report on Thursday, February 23rd. Sanford C. Bernstein initiated coverage on shares of DaVita in a research note on Tuesday, March 7th. They issued a “market perform” rating on the stock. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research report on Friday, December 9th. Deutsche Bank Aktiengesellschaft increased their price target on shares of DaVita from $72.00 to $85.00 in a research report on Thursday, February 23rd. Finally, Cowen lifted their price objective on DaVita from $76.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, February 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, DaVita has an average rating of “Hold” and an average price target of $86.43.

Insider Buying and Selling

In related news, Director Charles Berg sold 735 shares of the company’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $81.78, for a total transaction of $60,108.30. Following the completion of the transaction, the director now owns 17,164 shares of the company’s stock, valued at $1,403,671.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.00% of the company’s stock.

About DaVita

(Get Rating)

DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.

Further Reading

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.